C-C趋化因子受体9通过小鼠小肠炎症调控肥胖诱导的胰岛素抵抗
该研究利用高脂饮食喂养的野生型与CCR9敲除小鼠,探讨CCR9在2型糖尿病发病中的作用。结果显示CCR9缺失改善糖耐量及胰岛素抵抗,减少小肠与内脏脂肪组织炎症,且过继转移CCR9表达T细胞可逆转此益处。结论提示CCR9通过诱导小肠炎症参与2型糖尿病发病,可作为经肠-内脏脂肪-肝轴的新治疗靶点。
要点
- CCR9缺失在高脂饮食下不改变体重,但显著改善糖耐量与胰岛素抵抗。
- CCR9缺失减少小肠IFN-γ产生CD4+ T细胞积聚及肠道通透性。
- 过继转移CCR9表达T细胞可部分逆转CCR9敲除小鼠的糖耐量获益。
核心结论
- CCR9通过诱导小肠炎症反应在2型糖尿病发病中起核心作用。
- CCR9可作为经肠-内脏脂肪-肝轴治疗2型糖尿病的新靶点。
研究设计与样本
- 使用雄性C57BL/6J野生型与CCR9敲除小鼠,喂食60%高脂饮食12周。
- 观察CCR9缺失对2型糖尿病代谢表型及炎症的影响。
主要发现
- 高脂饮食下野生型与CCR9敲除小鼠体重增加相当,但CCR9敲除小鼠糖耐量和胰岛素抵抗显著改善。
- CCR9敲除小鼠内脏脂肪组织和肝脏炎症减轻,糖代谢相关基因表达增加。
- 野生型小鼠高脂饮食后小肠IFN-γ产生CD4+ T细胞积聚及肠道通透性增加,CCR9敲除小鼠中这些变化被抑制。
- 过继转移肠道趋向性CCR9表达T细胞通过加剧小肠和内脏脂肪组织炎症,部分逆转CCR9敲除小鼠的糖耐量获益。
临床怎么用
- 提示CCR9及相关小肠炎症通路可能成为2型糖尿病治疗干预的新方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Accumulation of adipose tissue macrophages is considered pivotal in the development of obesity-associated inflammation and insulin resistance. In addition, recent studies suggest an involvement of the intestine as the primary organ in inducing hyperglycaemia and insulin resistance. We have reported that the C-C motif chemokine receptor (CCR) CCR9 is associated with intestinal immunity and has a pathogenic role in various liver diseases. However, its contribution to type 2 diabetes is unknown. In the current study, we aimed to clarify the involvement of CCR9 in the pathology of type 2 diabetes and the potential underlying mechanisms. METHODS: To elucidate how CCR9 affects the development of metabolic phenotypes, we examined the impact of CCR9 deficiency on the pathogenesis of type 2 diabetes using male C57BL/6J (wild-type [WT]) and CCR9-deficient (CCR9 knockout [KO]) mice fed a 60% high-fat diet (HFD) for 12 weeks. RESULTS: WT and Ccr9KO mice fed an HFD exhibited a comparable weight gain; however, glucose tolerance and insulin resistance were significantly improved in Ccr9KO mice. Moreover, visceral adipose tissue (VAT) and the liver of Ccr9KO mice presented with less inflammation and increased expression of glucose metabolism-related genes than WT mice. Ccr9 and Ccl25 expression were specifically higher in the small intestine but was not altered by HFD feeding and type 2 diabetes development. Accumulation of IFN-γ-producing CD4+ T lymphocytes and increased intestinal permeability in the small intestine was observed in WT mice following HFD feeding, but these changes were suppressed in HFD-fed Ccr9KO mice. Adoptive transfer of gut-tropic CCR9-expressing T lymphocytes partially reversed the favourable glucose tolerance found in Ccr9KO mice via exacerbated inflammation in the small intestine and VAT. CONCLUSIONS/INTERPRETATION: CCR9 plays a central role in the pathogenesis of type 2 diabetes by inducing an inflammatory shift in the small intestine. Our findings support CCR9 as a new therapeutic target for type 2 diabetes via the gut-VAT-liver axis.
引用
- Amiya T, Nakamoto N, Irie J, et al. C-C motif chemokine receptor 9 regulates obesity-induced insulin resistance via inflammation of the small intestine in mice. Diabetologia. 2021. PMID: 33399911. doi:10.1007/s00125-020-05349-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。